Apr 11, 2007 7:30am EDT Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
Mar 14, 2007 7:30am EDT Rigel Announces Presentation at the Lehman Brothers Global Healthcare Conference
Feb 13, 2007 7:30am EST Rigel Announces Initiation of Phase 1 Study Evaluating R763 in Hematological Malignancies
Jan 08, 2007 7:30am EST Rigel Announces Initiation of Phase II Study Evaluating R788 in Immune Thrombocytopenic Purpura (ITP)
